Sutro Biopharma Q1 EPS $(0.91) Misses $(0.71) Estimate, Sales $17.40M Beat $11.61M Estimate

Author: Benzinga Newsdesk | May 08, 2025 04:42pm
Sutro Biopharma (NASDAQ:STRO) reported quarterly losses of $(0.91) per share which missed the analyst consensus estimate of $(0.71) by 28.17 percent. This is a 4.21 percent increase over losses of $(0.95) per share from the same period last year. The company reported quarterly sales of $17.40 million which beat the analyst consensus estimate of $11.61 million by 49.85 percent. This is a 33.76 percent increase over sales of $13.01 million the same period last year.

Posted In: STRO